HealthEquity (NASDAQ:HQY) announced its fiscal 2021 first-quarter results after the market closed on Tuesday. The consumer-directed benefits administrator reported revenue of $190 million, lower than the consensus Wall Street estimate of $193.3 million.

For the period, which ended April 30, the company posted GAAP earnings of $1.8 million, or $0.03 per diluted share. HealthEquity's adjusted (non-GAAP) earnings were $30.8 million, or $0.43 per diluted share. Analysts' average estimate for adjusted earnings had been $0.44 per share. 

Blocks spelling HSA next to a $100 bill rolled up

Image source: Getty Images.

Growth drivers

HealthEquity's revenue jumped 118% year over year. This growth was driven partly by its acquisition of WageWorks, which closed in August. The company reported the number of health savings accounts (HSAs) under management increased 33% year over year to around 5.4 million. 

GAAP earnings plunged 95% from the prior-year period due to higher operating expenses that were largely related to the addition of WageWorks. However, HealthEquity's non-GAAP earnings increased 12% year over year due primarily to its higher revenue and adjustments related to the amortization of acquired intangible assets, merger integration expenses, and income tax provisions.


HealthEquity withdrew its fiscal 2021 guidance due to uncertainties related to the COVID-19 pandemic. The company projects fiscal Q2 revenues of between $168 million and $173 million. It also expects a Q2 GAAP net loss of between $20 million and $15 million, or $0.27 to $0.21 per diluted share. HealthEquity looks for Q2 non-GAAP earnings of between $17 million and $22 million, or $0.23 to $0.30 per diluted share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.